-
-
-
-
-
-
-
RedHill initiates enforcement of $10.9 million judgment in Korea
-
-
-
-
-
-
-
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
-
-
-
-
-
-
-
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
-
-
-
-
-
-
-
Cumberland Pharmaceuticals invests $4 million in RedHill's Talicia business
-
-
-
-
-
-
-
RedHill Biopharma wins $1.8M in legal costs from New York court
-
-
-
-
-
-
-
RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
-
-
-
-
-
-
-
RedHill Biopharma's (RDHL) Positive Opaganib Weight Loss & Diabetes Data Published
-
1,177,429 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

